Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD

Summary Background Lung mucociliary clearance is impaired in patients with chronic obstructive pulmonary disease (COPD). Treatment guidelines recommend that patients with COPD receive maintenance therapy with long-acting beta-agonists and anticholinergic agents. Methods Twenty-four patients with mil...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory medicine 2011-06, Vol.105 (6), p.900-906
Hauptverfasser:	Meyer, Thomas, Reitmeir, Peter, Brand, Peter, Herpich, Christiane, Sommerer, Knut, Schulze, Anja, Scheuch, Gerhard, Newman, Stephen
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Adult Aged Biological and medical sciences Bronchodilator Agents - administration & dosage Bronchodilator Agents - pharmacology Chronic obstructive pulmonary disease, asthma Cross-Over Studies Drug dosages Drug therapy Drug Therapy, Combination Dry Powder Inhalers Ethanolamines - administration & dosage Ethanolamines - pharmacology Female Forced Expiratory Volume - drug effects Forced Expiratory Volume - physiology Formoterol Formoterol Fumarate Humans Male Medical sciences Middle Aged Mucus - drug effects Mucus - secretion Mucus clearance Personal relationships Pneumology Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - psychology Pulmonary/Respiratory Quality of Life - psychology Retention Scopolamine Derivatives Smoking Spirometry Tiotropium Bromide
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!